ViaDerma, Inc. (VDRM)

OTCMKTS · Delayed Price · Currency is USD
0.0004
0.00 (0.00%)
Mar 6, 2026, 9:30 AM EST
-96.64%
Market Cap 493.49K
Revenue (ttm) 44.69K
Net Income (ttm) -1.52M
Shares Out 1.23B
EPS (ttm) -0.00
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 18,725
Average Volume 70,694
Open 0.0004
Previous Close 0.0004
Day's Range 0.0004 - 0.0004
52-Week Range 0.0001 - 0.0235
Beta 0.15
RSI 55.64
Earnings Date n/a

About ViaDerma

ViaDerma, Inc., through its subsidiary, manufactures and sells pharmaceutical related products in the United States. The company’s lead product is Vitastem, a tetracycline and topical delivery technology for antibiotics to pain relief, skincare, and other. It is also developing various products for vitiligo, psoriasis, eczema, and other skin conditions using SkinPass topical delivery system, as well as antifungal, cosmetics, and pain management products. In addition, company develops anti-aging skin care, pain management, hair-loss, and toenail... [Read more]

Sector Healthcare
Founded 2007
Employees 75
Stock Exchange OTCMKTS
Ticker Symbol VDRM
Full Company Profile

Financial Performance

In 2017, ViaDerma's revenue was $44,691, a decrease of -82.26% compared to the previous year's $251,981. Losses were -$1.52 million, 1146.6% more than in 2016.

Financial Statements

News

There is no news available yet.